Risk factors associated with mortality in methanol-exposed patients at a public hospital in Lima, Peru

Authors

  • Jaime Zegarra Piérola Unidad de Cuidados Intensivos, Hospital Nacional Cayetano Heredia. Lima, Perú. / Universidad Peruana Cayetano Heredia. Lima, Perú. https://orcid.org/0000-0002-9956-7810
  • Diana Callo Rodrigo Unidad de Cuidados Intensivos, Hospital Nacional Cayetano Heredia. Lima, Perú.
  • Luz Carbajal Arroyo Universidad Peruana Cayetano Heredia. Lima, Perú.

DOI:

https://doi.org/10.20453/rmh.v36i4.6019

Keywords:

Methanol, lactic acid, critical care

Abstract

Methanol poisoning is a neuro-metabolic emergency that can cause severe metabolic acidosis, cerebral dysfunction, and death. Objective: To describe the factors associated with mortality in patients with methanol poisoning treated at a general hospital in Lima, Peru. Methods: A descriptive, case series study was conducted. It included patients admitted to the Intensive Care Unit of Hospital Nacional Cayetano Heredia with cerebral dysfunction and hyperlactatemia after ingesting the alcoholic beverage "Punto D Oro," between September and October 2022. Results: Thirteen patients were evaluated; 10 were male (77%), with an average age of  39 ± 6,96 years and a duration of illness of  3,5 ± 2,4 hours; 100% presented with blurred vision and altered sensorium; 81% had abdominal pain. The average APACHE II score was 19,5 ± 4,98 and the SOFA score was 11,3 ± 2,17; systolic blood pressure was  118,3 ± 20,70 mm Hg, diastolic blood pressure 66,1 ± 9,49 mm Hg, heart rate  107,5 ± 28,04 beats/min, respiratory rate  25,1 ± 5,39 breaths/min, and Glasgow Coma Scale (GCS) score was 9 (range 4–15). Lactate was  8,8 ± 3,88 mmol/L; pH 6,8 ± 0,16;   HCO₃⁻ 4,8 ± 1,33 mEq/L; anion gap 38,6 ± 7,81. The overall mortality was 23.07%. Factors associated with higher mortality were: lower Glasgow Coma Scale score (p=0.009), higher SOFA score (p=0.04), elevated lactate (p=0.017), and low bicarbonate on the third day (p = 0.042). Conclusion: Mortality was 23.07% and was significantly related to greater neurological severity, greater organ dysfunction, and more severe metabolic acidosis.

Downloads

Download data is not yet available.

Author Biographies

Jaime Zegarra Piérola, Unidad de Cuidados Intensivos, Hospital Nacional Cayetano Heredia. Lima, Perú. / Universidad Peruana Cayetano Heredia. Lima, Perú.

b

Diana Callo Rodrigo , Unidad de Cuidados Intensivos, Hospital Nacional Cayetano Heredia. Lima, Perú.

b

Luz Carbajal Arroyo , Universidad Peruana Cayetano Heredia. Lima, Perú.

b

References

Jacobsen D, McMartin KE. Methanol and ethylene glycol poisonings: mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol. 1986; 1:309–34. doi:10.1007/BF03259846

Latus J, Kimmel M, Alscher MD, Braun N. Ethylene glycol poisoning: a rare but life-threatening cause of metabolic acidosis — a single-centre experience. Clin Kidney J. 2012; 5:120–3. doi:10.1093/ckj/sfs009

Ministerio de Salud. DIGESA. Comunicado 21-2022-DIGESA-MINSA-01. 2022. Disponible en: https://www.digesa.minsa.gob.pe/COMUNICADO_21-2022-DIGESA-MINSA-01.pdf

Treichel JL, Murray TG, Lewandowski MF, Stueven HA, Eells JT, Burke JM. Retinal toxicity in methanol poisoning. Retina. 2004;24(2):309–12. doi:10.1097/00006982-200404000-00023

Hovda KE, Hunderi OH, Tafjord AB, Dunlop O, Rudberg N, Jacobsen D. Methanol outbreak in Norway 2002–2004: epidemiology, clinical features and prognostic signs. J Intern Med. 2005;258:181–90. doi:10.1111/j.1365-2796.2005.01521.x

Haviv YS, Rubinger D, Zamir E, Safadi R. Pseudo-normal osmolal and anion gaps following simultaneous ethanol and methanol ingestion. Am J Nephrol. 1998;18:436–8. doi:10.1159/000013366

Kraut JA. Diagnosis of toxic alcohols: limitations of present methods. Clin Toxicol (Phila). 2015;53:589–95. doi:10.3109/15563650.2015.1056880

Shin JM, Sachs G, Kraut JA. Simple diagnostic tests to detect toxic alcohol intoxications. Transl Res. 2008;152:194–201. doi:10.1016/j.trsl.2008.07.002

Krasowski MD, Wilcoxon RM, Miron J. A retrospective analysis of glycol and toxic alcohol ingestion: utility of anion and osmolal gaps. BMC Clin Pathol. 2012;12:1. doi:10.1186/1472-6890-12-1

Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002;40:415–46. doi:10.1081/clt-120006745

Brent J. Fomepizole for ethylene glycol and methanol poisoning. N Engl J Med. 2009;360:2216–23. doi:10.1056/NEJMct0806112

World Health Organization. WHO model list of essential medicines: 18th list. Geneva: WHO; 2013.

Beatty L, Green R, Magee K, Zed P. A systematic review of ethanol and fomepizole use in toxic alcohol ingestions. Emerg Med Int. 2013;2013:638057. doi:10.1155/2013/638057

Lepik KJ, Levy AR, Sobolev BG, et al. Adverse drug events associated with the antidotes for methanol and ethylene glycol poisoning: a comparison of ethanol and fomepizole. Ann Emerg Med. 2009;53(4):439–50.e10. doi:10.1016/j.annemergmed.2008.05.008

Kraut JA, Mullins ME. Toxic alcohols. N Engl J Med. 2018;378(3):270–80. doi:10.1056/NEJMra1615295

Published

2025-12-19

How to Cite

1.
Zegarra Piérola J, Callo Rodrigo D, Carbajal Arroyo L. Risk factors associated with mortality in methanol-exposed patients at a public hospital in Lima, Peru. Rev Méd Hered [Internet]. 2025 Dec. 19 [cited 2025 Dec. 30];36(4):345-52. Available from: http://44.198.254.164/index.php/RMH/article/view/6019

Most read articles by the same author(s)

1 2 > >>